Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VNMEVendome Acquisition Corp I

Nasdaq · CIK 0002055879
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts70

Identity from submissions API

NameVendome Acquisition Corp I
CIK0002055879
TickersVNME, VNMEU, VNMEW
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone435-714-7973
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1090 CENTER DRIVE
PARK CITY
UT
84098
UT
Mailing address
1090 CENTER DRIVE
PARK CITY
UT
84098
UT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

44 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001905106-26-000212 005-95114 261558743 34 7626
2026-11-13 10-Q 10-Q 0001140361-26-043810 001-42722 261553837 34 3780517 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001905106-26-000149 005-95114 261279863 34 7644
2026-08-12 10-Q 10-Q 0001140361-26-032487 001-42722 261267697 34 3675740 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001604488-26-000076 005-95114 26988536 34 16844
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001905106-26-000108 005-95114 26985496 34 7619
2026-05-14 10-Q 10-Q 0001140361-26-021287 001-42722 26978862 34 3448733 1 1
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000057 005-95114 26978191 34 9456
2026-03-20 10-K 10-K 0001140361-26-010592 001-42722 26779179 34 4682791 1 1
2026-02-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001905106-26-000051 005-95114 26631967 34 7476
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-26-000033 005-95114 26619423 34 6046
2025-11-19 10-Q 10-Q 0001140361-25-042736 001-42722 251499547 34 3544637 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001604488-25-000238 005-95114 251487996 34 16667
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001905106-25-000081 005-95114 251487572 34 7492
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-042315 005-95114 251486464 34 11202
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-282895 005-95114 251485744 34 16709
2025-11-14 NT 10-Q NT 10-Q 0001140361-25-042290 001-42722 251485541 34 23429
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001076809-25-000137 005-95114 251479393 34 9022
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-25-000605 005-95114 251473534 34 5993
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-109833 005-95114 251469219 34 26790
2025-08-21 8-K 8-K 8.01,9.01 0001140361-25-032231 001-42722 251241701 34 232444 1 1
2025-08-14 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) 0001140361-25-031288 001-42722 251220287 34 2695687 1 1
2025-08-14 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) 0001140361-25-031260 001-42722 251219986 34 2744349 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-031208 005-95114 251218392 34 17707
2025-07-10 8-K 8-K 8.01,9.01 0001140361-25-025494 001-42722 251116482 34 168939
2025-07-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-094767 005-95114 251113564 34 16716
2025-07-03 8-K 8-K 1.01,3.02,5.02,5.03,8.01,9.01 0001140361-25-024847 001-42722 251105738 34 1138548
2025-07-02 424B4 424B4 0001140361-25-024650 333-286534 251101239 33 2522203
2025-06-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002087 333-286534 251094048 33 1710
2025-06-30 3 FORM 3 0001140361-25-024234 11046
2025-06-30 3 FORM 3 0001140361-25-024233 4332
2025-06-30 3 FORM 3 0001140361-25-024232 4329
2025-06-30 CERT 8A_CERT_VNME.pdf 0001354457-25-000594 001-42722 251092573 34 123662
2025-06-30 8-A12B 8-A12B 0001140361-25-024112 001-42722 251088990 34 13433
2025-06-26 CORRESP filename1.htm 0001140361-25-023788 5826
2025-06-26 CORRESP filename1.htm 0001140361-25-023787 8141
2025-06-25 S-1/A S-1/A 0001140361-25-023640 333-286534 251073560 33 809790
2025-06-23 CORRESP filename1.htm 0001140361-25-023282 1053733
2025-06-23 S-1/A S-1/A 0001140361-25-023280 333-286534 251063388 33 5080425
2025-06-20 UPLOAD filename1.pdf 0000000000-25-006500 333-286534 44179
2025-06-06 CORRESP filename1.htm 0001140361-25-021824 77959
2025-06-06 S-1/A FORM S-1/A 0001140361-25-021822 333-286534 251032142 33 3514692
2025-05-13 UPLOAD filename1.pdf 0000000000-25-005055 333-286534 51690
2025-04-15 S-1 S-1 0001140361-25-013881 333-286534 25837826 33 3358583

Latest XBRL company facts

One latest value per concept from companyfacts (70 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 200.60M 2025-06-30 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 184,360 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 7,729 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-03-31 2026 Q1 10-Q 2026-05-14 0001140361-26-021287
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 41,257 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 2.65M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001140361-26-032487
us-gaap Assets Assets USD 209.65M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap AssetsCurrent Assets, Current USD 596,273 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2025-12-31 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 209.05M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap Cash Cash USD 393,206 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 393,206 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 88,630 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 143,206 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 12.65M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1 2025-01-28 2025-06-30 2025 Q2 10-Q 2025-08-14 0001140361-25-031288
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2025-12-31 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap DerivativeLiabilities Derivative Liability USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2025-01-28 2025-06-30 2025 Q2 10-Q 2025-08-14 0001140361-25-031288
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2025-01-28 2025-06-30 2025 Q2 10-Q 2025-08-14 0001140361-25-031288
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 82,951 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001140361-26-032487
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -66,174 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 9.43M 2025-07-03 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap Liabilities Liabilities USD 342,089 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 209.65M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap LiabilitiesCurrent Liabilities, Current USD 157,729 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2025-12-31 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 375,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -286,370 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 4.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 2.11M 2025-07-03 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 525,495 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap OperatingExpenses Operating Expenses USD 525,495 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 2.06M 2025-01-28 2025-12-31 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 1.00M 2025-07-03 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 203,067 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 3.47M 2025-01-28 2025-12-31 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 60,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-12 0001140361-26-032487
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 253,684 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap SharePrice Share Price USD/shares 18 2025-09-30 2025 Q3 10-Q 2025-11-19 0001140361-25-042736
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 254,184 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 25,000 2025-01-29 2025-03-31 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 0 2025-05-25 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 0 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 5.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 209.05M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap TimeDepositsAtOrAboveFDICInsuranceLimit Time Deposits, at or Above FDIC Insurance Limit USD 54,576 2025-12-31 2025 FY 10-K 2026-03-20 0001140361-26-010592
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001140361-26-043810
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2025-09-30 2025 Q3 10-Q 2025-11-19 0001140361-25-042736
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.92M 2025-01-28 2025-06-30 2025 Q2 10-Q 2025-08-14 0001140361-25-031288
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.92M 2025-01-28 2025-06-30 2025 Q2 10-Q 2025-08-14 0001140361-25-031288

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →